Nowadays, treatment strategies have been developed for the management of AD with the use of acetylcholinesterase (AChE) inhibitors (an enzyme principally involved in the hydrolysis of acetylcholine) (Jukic et al., 2007). The gene discussed is ACHE; the disease is Alzheimer disease.